STAGE IV GALLBLADDER CANCER AJCC V8
Clinical trials for STAGE IV GALLBLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV GALLBLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV GALLBLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test Triple-Threat attack on Tough-to-Treat cancers
Disease control OngoingThis study is testing a new three-part treatment for people with advanced cancers that have spread. It combines a new pill (peposertib), an immunotherapy drug (avelumab), and a short, high-dose course of radiation. The goal is to see if this combination can better control cancer …
Matched conditions: STAGE IV GALLBLADDER CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New hope for Tough-to-Treat bile duct cancers
Disease control OngoingThis study is for people with advanced bile duct, gallbladder, or liver bile duct cancer that has worsened after initial treatment. It tests whether adding a targeted pill called binimetinib to standard chemotherapy (FOLFOX) helps patients live longer and better control the cance…
Matched conditions: STAGE IV GALLBLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC